Open access
Aug 2026
Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology
Primary tumors show an immunosuppressive phenotype, suggesting potential benefits from combining CTLA4 or IDO1 inhibitors with PD-1 blockade, and Liver metastases exhibit distinct immune features, supporting the need for site-specific precision therapies.
Ying Lu, T. Han, Li-Hui Wang et al.
· Frontiers in Oncology · 0 citations